The Bull Case For Viking Therapeutics (VKTX) Could Change Following New Oral VK2735 Obesity Data Release [Yahoo! Finance]
Viking Therapeutics, Inc. (VKTX)
Last viking therapeutics, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.vikingtherapeutics.com
Company Research
Source: Yahoo! Finance
VK2735 produced statistically significant, dose-dependent weight loss over 13 weeks with mostly mild to moderate side effects in adults with obesity and common cardiometabolic risk factors. A key takeaway for investors is that oral VK2735 delivered early, progressive weight loss without a clear 13-week plateau, hinting at a potentially differentiated oral obesity therapy alongside injectable formulations if longer-term studies support these findings. We'll now examine how oral VK2735's early, dose-dependent weight loss profile could reshape Viking's investment narrative and future prospects. The latest GPUs need a type of rare earth metal called Dysprosium and there are only 30 companies in the world exploring or producing it . Find the list for free. Viking Therapeutics Investment Narrative Recap To own Viking Therapeutics, you need to believe VK2735 can turn today's zero revenue and sizeable net losses into a viable obesity franchise across injectable and oral formats. The
Show less
Read more
Impact Snapshot
Event Time:
VKTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VKTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VKTX alerts
High impacting Viking Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
VKTX
News
- Viking Therapeutics CMO Hire Puts Spotlight On Pipeline Progress And Valuation [Yahoo! Finance]Yahoo! Finance
- Is Viking Therapeutics Stock Going to $100? [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- Viking Therapeutics Announces Appointment of Hubert C. Chen, M.D., as Chief Medical Officer [Yahoo! Finance]Yahoo! Finance
- Viking Therapeutics Announces Appointment of Hubert C. Chen, M.D., as Chief Medical OfficerPR Newswire
- Viking Therapeutics: Drugs Are In The Pipeline, But Profitability Is Still Unproven [Seeking Alpha]Seeking Alpha
VKTX
Earnings
- 4/29/26 - Miss
VKTX
Sec Filings
- 6/3/26 - Form 4
- 6/3/26 - Form 3
- 5/26/26 - Form 8-K
- VKTX's page on the SEC website